Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Breast Carcinoma|Metastatic Carcinoma in the Liver|Prognostic Stage IV Breast Cancer AJCC v8
Interventions: DEVICE: Y-90 SIR-Spheres|PROCEDURE: Yttrium-90 Microsphere Radioembolization|OTHER: Systemic Therapy
Sponsor: Emory University
Collaborators: National Cancer Institute (NCI)|Sirtex Medical